Delivery Order SPE2DB20D1110-SPE2DB25FK35K
- Not listed
- The Defense Logistics Agency awarded a $2,117.00 delivery order to AmerisourceBergen Drug Corp for Testosterone Cypionate 200 mg/mL on July 23, 2025, with completion expected by July 24, 2025. This competitively awarded, firm fixed-price contract represents a child delivery order under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), valued at $999.999 billion through December 2026. The contract carries no set-aside designation and will be...
- The Defense Logistics Agency (DLA) awarded a $1,713.12 delivery order to AmerisourceBergen Drug Corp on August 5, 2025, for the supply of Testosterone Cypionate 2,000 mg/10mL vials. This competitively awarded, non-set-aside contract features firm fixed pricing and a delivery completion date of August 6, 2025. The work will be performed at AmerisourceBergen's corporate office in Conshohocken, Pennsylvania. This delivery order represents a single transaction under the company's broader...
- The Defense Logistics Agency awarded a delivery order valued at $1,528.26 to AmerisourceBergen Drug Corp for the supply of Testosterone Cypionate 200 mg/mL on August 7, 2025, with an ultimate completion date of August 8, 2025. This is a firm fixed price delivery order with no set-aside designation, competitively awarded under open competition. The pharmaceutical product will be delivered to AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania, where the company maintains...
- The Defense Logistics Agency awarded a $3,040.02 delivery order to AmerisourceBergen Drug Corp for Testosterone Cypionate 200 mg/mL on August 8, 2025, with an ultimate completion date of August 11, 2025. This is a competitively awarded, firm fixed price contract with no set-aside designation. The pharmaceutical product will be delivered to the company's facility in Conshohocken, Pennsylvania. This delivery order is issued under AmerisourceBergen's larger Indefinite Delivery Contract (IDC)...
- The Defense Logistics Agency awarded a $1,786.65 delivery order to AmerisourceBergen Drug Corp for Testosterone Cypionate 200 mg/mL on July 25, 2025, with an ultimate completion date of July 28, 2025. This firm fixed-price contract, issued without set-aside designation, represents a competitive award executed under AmerisourceBergen's existing Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), a $999.99 billion prime vehicle running through December 2026. The place of...
- The Defense Logistics Agency awarded a $2,122.84 firm fixed-price delivery order to AmerisourceBergen Drug Corp for Testosterone Cypionate 200 mg/mL, with an ultimate completion date of July 21, 2025. This non-set-aside contract represents a pediatric or clinical pharmaceutical supply requirement typical of federal medical procurement operations. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, is a major pharmaceutical distributor serving as a critical vendor for...
- The Defense Logistics Agency awarded AmerisourceBergen Drug Corp a delivery order valued at $3,761.52 on July 22, 2025, for the supply of Testosterone Cypionate 2,000 mg/10mL vials. This firm fixed-price delivery order, which is not set-aside designated, will be performed at the contractor's corporate office location in Conshohocken, Pennsylvania, with an ultimate completion date of July 23, 2025. The award represents a single-item pharmaceutical procurement supporting military healthcare supply...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for Testosterone Cypionate 200 mg/mL with a ceiling value of $1,416.00. This firm fixed-price delivery order, awarded on August 12, 2025, with an ultimate completion date of August 13, 2025, represents a child contract with no set-aside designation. AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, fulfilled this order from its corporate office...
- This delivery order, valued at $1,416.00, was awarded to AmerisourceBergen Drug Corp on August 5, 2025, by the Defense Logistics Agency (DLA) for the supply of Testosterone Cypionate 200 mg/mL. The contract is a firm fixed-price delivery order with performance scheduled to conclude on August 6, 2025. The place of performance is located in Conshohocken, Pennsylvania, where AmerisourceBergen Drug Corp maintains its corporate headquarters. No set-aside designation was applied to this competitive...
- The Defense Logistics Agency awarded a delivery order valued at $1,404.76 to AmerisourceBergen Drug Corp for the supply of Testosterone Cypionate 1,000 mg/10 mL (10 mL vials). This non-set-aside contract was executed on August 5, 2025, with an ultimate completion date of August 6, 2025, utilizing firm fixed-price terms. The place of performance is AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is issued under AmerisourceBergen's larger Indefinite...
- SPE2DB20D1110Indefinite Delivery Contract
- SPE2DB20D1110-SPE2DB25FK35KDelivery Order
The Defense Logistics Agency awarded a delivery order valued at $1,207.32 to AmerisourceBergen Drug Corp for the supply of Testosterone Cypionate 200 mg/mL. This firm fixed-price contract, awarded on August 19, 2025, with an ultimate completion date of August 20, 2025, represents a non-competitive set-aside arrangement and will be performed at the contractor's corporate office location in Conshohocken, Pennsylvania. The delivery order falls under AmerisourceBergen's broader pharmaceutical supply relationship with the federal government. This delivery order is a child contract under AmerisourceBergen Drug Corp's Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, a comprehensive $999.99 billion pharmaceutical support vehicle running through December 2026. AmerisourceBergen serves as a critical pharmaceutical distributor for the Defense Health Agency, U.S. Coast Guard, and other federal healthcare systems, supplying a wide range of medications, vaccines, medical devices, and healthcare commodities across multiple therapeutic domains. The company's federal procurement portfolio demonstrates consistent capability in fulfilling competitive medical supply requirements with firm fixed-price delivery orders across various product categories and dollar values.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $1.2k | 8/19/25 |